Plasma on transurethral resection of the clinical efficacy of benign prostatic hyperplasia.doc

 PAGE \* MERGEFORMAT 8 Plasma on transurethral resection of the clinical efficacy of benign prostatic hyperplasia [Abstract] Objective To investigate plasma and analysis of transurethral resection of benign prostatic hyperplasia patients. Methods January 2009 to January 2010 to our hospital 125 cases of benign prostatic hyperplasia were enrolled, all of its transurethral resection of plasma treatment, retrospective analysis of its clinical efficacy. Results of 125 cases the operations were successful, the operation time 30-135 minutes, with an average 52.3 minutes, the weight of 18-105 grams of resected prostate tissue, an average of 43.9 grams, surgery the bleeding 16-250ml, average 59.8ml. preoperative and postoperative quality of life 6 months scores (QOL), maximum urinary flow rate (Qmax) and International Prostate Symptom Score (IPSS) index by comparison, are (p lt; 0.05 statistically significant difference. Conclusion Transurethral resection of plasma treatment of benign prostatic hyperplasia is a safe and effective surgical method, is worthy of clinical use. [Keywords: plasma transurethral resection of prostate hyperplasia Patients with benign prostatic hyperplasia is a common disease in older men, one with an increasingly aging population in our society, making the incidence rate of the rise year by year growth. Transurethral resection of the plasma is transurethral resection of the prostate developed on the basis of A new surgical method [1], in order to investigate the treatment of benign prostatic hyperplasia safety and efficacy, this article in our hospital from January 2009 to January 2010 125 cases of benign prostatic hyperplasia treatment were enrolled and given by urethral resection of plasma treatment, achieved a good clinical effect, analysis of reports are as follows: 1 Materials and Methods 1.1 General Information Select January 2009 to January 2010 to our hospital 125 cases of benign prostatic hyperplasia were enrolled,